![]() Cipla Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases. | ![]() Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. | EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | ||
Founding Date | Founding Date 1978 | Founding Date 1935 | Founding Date 2017 | Founding Date 1964 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Bengaluru, IN HQ Bengaluru, IN Hyderabad, IN Visakhapatnam, IN Dublin, IE Kuala Lumpur, MY Puchong, MY see more | Locations Mumbai, IN HQ South Melbourne, AU Mumbai, IN Nairobi, KE Cape Town, ZA Durban, ZA Durban, ZA see more | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | Locations BR HQ |
Employees | Employees 15,000 | Employees 23,043 | Employees 8007% increase | Employees 10,7637% increase |
Twitter followers | Twitter followers 21.7 k | Twitter followers 33.8 k | Twitter followers 2.1 k | Twitter followers 1.2 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 47 | Number of tweets (last 30 days) 29 | Number of tweets (last 30 days) 12 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 3.1 | Average likes per tweet (last 30 days) 3.3 | Average likes per tweet (last 30 days) 4.3 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 97.87% | Percentage of tweets with engagement (last 30 days) 68.97% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Employee Rating | Employee Rating 3.8 | Employee Rating 3.9 | Employee Rating 3.7 | Employee Rating 3.8 |
Financial | ||||
Revenue (est.) | Revenue (est.) ₹80.2b (FY, 2022) | Revenue (est.) ₹224.7b (FY, 2023) | Revenue (est.) CHF97.1m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods ₹28.8b (FY, 2022) | Cost of goods ₹82.5b (FY, 2023) | Cost of goods CHF6.3m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit ₹58.1b (FY, 2022) | Gross profit ₹149.8b (FY, 2023) | Gross profit CHF90.8m (FY, 2022) | Gross profit N/A |
Net income | Net income ₹7.7b (FY, 2022) | Net income ₹28.4b (FY, 2023) | Net income (CHF827.9m) (FY, 2022) | Net income N/A |
Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases.
View companyIdorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
View companyEMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
View company